Age-stratified comparison of active surveillance versus radiofrequency ablation for papillary thyroid microcarcinoma using decision analysis.

[1]  James A. Lee,et al.  If the price is right: Cost-effectiveness of radiofrequency ablation versus thyroidectomy in the treatment of benign thyroid nodules. , 2022, Surgery.

[2]  Anirudh Saraswathula,et al.  Cost comparison between open thyroid lobectomy and radiofrequency ablation for management of thyroid nodules , 2022, Head & neck.

[3]  J. Doyle,et al.  Constructing Health State Descriptions for Low-Risk Thyroid Cancer: Stakeholder Engagement and Formative Qualitative Research , 2022, The Patient - Patient-Centered Outcomes Research.

[4]  M. Unlu,et al.  The Reality of Hypoparathyroidism After Thyroidectomy: Which Risk Factors are Effective? Single-Center Study , 2022, Sisli Etfal Hastanesi tip bulteni.

[5]  Sun Wook Cho,et al.  Active Surveillance Versus Immediate Surgery for Low-Risk Papillary Thyroid Microcarcinoma Patients in South Korea: A Cost-Minimization Analysis from the MAeSTro Study. , 2022, Thyroid : official journal of the American Thyroid Association.

[6]  J. Olson,et al.  Treat Now or Treat Later: Comparative Effectiveness of Adjuvant Therapy in Resected Stage IIIA Melanoma. , 2022, Journal of the American College of Surgeons.

[7]  Yaqian Mao,et al.  Economic effect between surgery and thermal ablation for patients with papillary thyroid microcarcinoma: a systemic review and meta-analysis , 2022, Endocrine.

[8]  Yukun Luo,et al.  Ultrasound-Guided Radiofrequency Ablation Versus Thyroid Lobectomy for Low-Risk Papillary Thyroid Microcarcinoma: A Propensity-matched Cohort Study of 884 Patients. , 2021, Thyroid : official journal of the American Thyroid Association.

[9]  I. Sugitani,et al.  Multifocality and Progression of Papillary Thyroid Microcarcinoma During Active Surveillance , 2021, World Journal of Surgery.

[10]  F. Stacul,et al.  Current Status and Challenges of US-Guided Radiofrequency Ablation of Thyroid Nodules in the Long Term: A Systematic Review , 2021, Cancers.

[11]  E. Papini,et al.  European Thyroid Association and Cardiovascular and Interventional Radiological Society of Europe 2021 Clinical Practice Guideline for the Use of Minimally Invasive Treatments in Malignant Thyroid Lesions , 2021, European Thyroid Journal.

[12]  H. Vermeersch,et al.  Risk factors for postoperative morbidity after thyroid surgery in a PROSPECTIVE cohort of 1500 patients. , 2021, International journal of surgery.

[13]  Yukun Luo,et al.  Evaluation of Ultrasound-Guided Radiofrequency Ablation as a Treatment Option for Papillary Thyroid Microcarcinoma in the Isthmus: A Retrospective Study , 2021, Frontiers in Endocrinology.

[14]  D. Hu,et al.  The Recovery of Thyroid Function in Low-Risk Papillary Thyroid Cancer After Lobectomy: A 3-Year Follow-Up Study , 2021, Frontiers in Endocrinology.

[15]  Mengying Tong,et al.  Long-term follow-up results of PTMC treated by ultrasound-guided radiofrequency ablation: a retrospective study , 2021, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[16]  Juan Liu,et al.  Ultrasound-guided thermal ablation for papillary thyroid microcarcinoma: a multicenter retrospective study , 2021, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[17]  Charles D Meyer,et al.  Prediction of Thyroid Hormone Replacement Following Thyroid Lobectomy: A Long-term Retrospective Study , 2021, OTO open.

[18]  B. Jarzab,et al.  Early Diagnosis of Low-Risk Papillary Thyroid Cancer Results Rather in Overtreatment Than a Better Survival , 2020, Frontiers in Endocrinology.

[19]  Yukun Luo,et al.  Long-term outcomes of radiofrequency ablation for unifocal low-risk papillary thyroid microcarcinoma: a large cohort study of 414 patients , 2020, European Radiology.

[20]  Hang-Seok Chang,et al.  Thyroid Hormone Supplementation Therapy for Differentiated Thyroid Cancer After Lobectomy: 5 Years of Follow-Up , 2020, Frontiers in Endocrinology.

[21]  M. Stang,et al.  Recurrent Laryngeal Nerve Injury After Thyroid Surgery: An Analysis of 11,370 Patients. , 2020, The Journal of surgical research.

[22]  J. Baek,et al.  Long-term Follow-up Results of Ultrasound-guided Radiofrequency Ablation for Low-risk Papillary Thyroid Microcarcinoma: More than 5 year follow-up for 84 tumors. , 2020, Thyroid : official journal of the American Thyroid Association.

[23]  R. Tuttle,et al.  Assessing the Number of Candidates There Are for Active Surveillance of Low-Risk Papillary Thyroid Cancers in the US. , 2020, JAMA otolaryngology-- head & neck surgery.

[24]  S. Prinja,et al.  Cost-Effectiveness Analysis and Decision Modelling: A Tutorial for Clinicians. , 2020, Journal of clinical and experimental hepatology.

[25]  N. Fleeman,et al.  Lenvatinib and sorafenib for differentiated thyroid cancer after radioactive iodine: a systematic review and economic evaluation. , 2020, Health technology assessment.

[26]  J. Baek,et al.  US-Guided Radiofrequency Ablation for Low-Risk Papillary Thyroid Microcarcinoma: Efficacy and Safety in a Large Population , 2019, Korean journal of radiology.

[27]  Wei Gao,et al.  Cost-effectiveness of pembrolizumab for the adjuvant treatment of resected high-risk stage III melanoma in the United States , 2019, Journal of medical economics.

[28]  I. Sugitani,et al.  Active Surveillance for T1bN0M0 Papillary Thyroid Carcinoma. , 2019, Thyroid : official journal of the American Thyroid Association.

[29]  Tae Yong Kim,et al.  Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma: A Multi-Center Cohort Study in Korea. , 2018, Thyroid : official journal of the American Thyroid Association.

[30]  B. Chang,et al.  A systematic approach to the recurrent laryngeal nerve dissection at the cricothyroid junction , 2018, Journal of Otolaryngology - Head & Neck Surgery.

[31]  Oscar Lin,et al.  Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance , 2017, JAMA otolaryngology-- head & neck surgery.

[32]  Jeong Hyun Lee,et al.  Safety of radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: a systematic review and meta-analysis , 2017, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[33]  H. Min,et al.  Radiofrequency ablation of low-risk small papillary thyroidcarcinoma: preliminary results for patients ineligible for surgery , 2017, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[34]  Jie Tang,et al.  Efficacy and Safety of Ultrasound-Guided Radiofrequency Ablation for Treating Low-Risk Papillary Thyroid Microcarcinoma: A Prospective Study. , 2016, Thyroid : official journal of the American Thyroid Association.

[35]  David F. Schneider,et al.  Hypoparathyroidism after total thyroidectomy: incidence and resolution. , 2015, The Journal of surgical research.

[36]  A. Miyauchi,et al.  Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. , 2014, Thyroid : official journal of the American Thyroid Association.

[37]  R. Seemann,et al.  Risk factors for postoperative bleeding after thyroid surgery , 2012, The British journal of surgery.

[38]  I. Sugitani,et al.  Three Distinctly Different Kinds of Papillary Thyroid Microcarcinoma should be Recognized: Our Treatment Strategies and Outcomes , 2010, World Journal of Surgery.

[39]  S. Mandel,et al.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[40]  R. Simó,et al.  Diagnosis of recurrent laryngeal nerve palsy after thyroidectomy: a systematic review , 2009, International journal of clinical practice.

[41]  K. Kaczirek,et al.  Hypoparathyroidism after total thyroidectomy: a prospective study. , 2008, Archives of surgery.

[42]  P. Yuen,et al.  A prospective evaluation of recurrent laryngeal nerve paralysis during thyroidectomy. , 2000, Archives of surgery.

[43]  A. Miyauchi,et al.  Estimation of the lifetime probability of disease progression of papillary microcarcinoma of the thyroid during active surveillance , 2018, Surgery.

[44]  A. Miyauchi,et al.  An Observational Trial for Papillary Thyroid Microcarcinoma in Japanese Patients , 2009, World Journal of Surgery.

[45]  L. Davies,et al.  Increasing incidence of thyroid cancer in the United States, 1973-2002. , 2006, JAMA.